Benefits
PMS symptom relief
A systematic review and meta-analysis of randomized trials found chasteberry associated with greater improvement in premenstrual symptoms than placebo across physical (bloating, breast tenderness, headache), behavioral (irritability, mood swings), and psychological (anxiety, low mood) domains, with responder rates around 50-80% in some trials. The review's authors cautioned that high risk of bias, heterogeneity in extract types/doses, and possible publication bias make the true effect size uncertain.
Cyclical mastalgia relief
Chasteberry is one of the better-studied botanicals for cyclical breast tenderness (mastalgia). Randomized trials have reported reductions in breast-tenderness scores with chasteberry extracts. A trial comparing chasteberry with the prescription drug bromocriptine has been reported in the literature, but it is not among the references cited on this page and should not be read as an established drug-equivalence claim.
Prolactin normalization and hormone balance
The dopamine agonist mechanism of chasteberry reduces elevated prolactin levels (latent hyperprolactinemia) — a key driver of luteal phase insufficiency, PMS symptoms, and irregular menstrual cycles. Research suggests that by supporting normal prolactin levels, chasteberry may help support luteal-phase progesterone and menstrual-cycle regularity, though much of the progesterone data comes from mechanistic and animal studies rather than human outcome trials.
Irregular menstrual cycle regulation
Chasteberry has traditionally been used to support more regular menstrual cycles, and some studies report improved cycle regularity over roughly 3 to 6 cycles. Rigorous controlled trials for irregular-cycle conditions such as oligomenorrhea or amenorrhea are limited and are not cited on this page.
Mechanism of action
Dopamine D2 receptor agonism and prolactin suppression
Chasteberry diterpenes (particularly rotundifuran) bind dopamine D2 receptors on pituitary lactotroph cells, inhibiting prolactin secretion. Since prolactin excess drives luteal phase insufficiency, breast pain, and many PMS symptoms, this dopaminergic mechanism is one proposed way chasteberry may support premenstrual comfort.
Mu-opioid receptor partial agonism
In laboratory studies, casticin and other chasteberry flavonoids show partial agonist activity at mu-opioid receptors — a preclinical finding that has been proposed, but not confirmed in humans, to contribute to pain and mood effects alongside the dopaminergic mechanism. This opioid pathway modulation may explain PMS-associated pain relief beyond prolactin reduction.
Progesterone receptor expression upregulation
By reducing prolactin and improving luteal phase function, chasteberry has been proposed to influence progesterone receptor expression and luteal-phase progesterone signaling in preclinical models; whether this meaningfully alters estrogen-progesterone balance in women remains unproven.
Clinical trials
Evidence review and pooled analysis of randomized, double-blind, placebo-controlled trials examining Vitex agnus-castus extract for premenstrual syndrome. (Verkaik et al. 2017, Am J Obstet Gynecol, PMID 28237870)
Pooled across multiple trials.
Vitex agnus-castus significantly more effective than placebo for overall PMS symptom reduction. Notable for breast tenderness, mood symptoms, and irritability. Effect sizes meaningful for moderate PMS. Note: heterogeneity in extract types and doses limits precise effect estimation; standardized extracts (Ze 440, Premular) have the strongest evidence.
Randomized, double-blind trial of chasteberry (Ze 440, 20 mg/day) vs bromocriptine (5 mg/day) vs placebo in women with cyclical mastalgia. (Breast)
Women with cyclical mastalgia (cyclic breast pain).
A reported comparison (not among the references cited here) suggested chasteberry reduced breast tenderness with tolerability better than the prescription drug bromocriptine; without a citation this should not be read as an established drug-equivalence result — bromocriptine commonly causes nausea and dizziness, while chasteberry was as well-tolerated as placebo. Note: bromocriptine is rarely used today for mastalgia due to its side effect profile; chasteberry is positioned as a gentler alternative.